• A case of chronic elephantiasis
• A dynamic game of lymphatic filariasis prevention by voluntary use of insecticide treated nets
• A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of AWZ1066S, an Anti-Wolbachia Candidate Macrofilaricide
• A pilot study to address the mental health of persons living with lymphatic filariasis in Leogane, Haiti: Implementing a chronic disease self-management program using a stepped-wedge cluster design
• A Rare Co-existent Case of Splenic Microfilariasis and Pancreatic Solid Pseudopapillary Epithelial Neoplasm - A Double Jeopardy!
• A review of epidemiology of lymphatic filariasis in Nigeria
• Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study
• An automated, high-resolution phenotypic assay for adult Brugia malayi and microfilaria
• An Ensemble Framework for Projecting the Impact of Lymphatic Filariasis Interventions Across Sub-Saharan Africa at a Fine Spatial Scale
• An evaluation of mental health integration in the neglected tropical diseases program in Zamfara, North-west Nigeria
• An Overview of Management Considerations for Mongolian Gerbils (<em>Meriones unguiculatus</em>), Cats (<em>Felis catus</em>), and Dogs (<em>Canis familiaris</em>) as Hosts for <em>Brugia</em> Infection
• An Unusual Encounter: Microfilaria Incidentally Detected in the Bone Marrow Aspirate of a Chronic Kidney Disease Patient
• Anti-dengue potential and mosquitocidal effect of marine green algae-stabilized Mn-doped superparamagnetic iron oxide nanoparticles (Mn-SPIONs): an eco-friendly approach
• Anti-filarial antibodies are sensitive indicators of lymphatic filariasis transmission and enable identification of high-risk populations and hotspots
• Assessment of Culicidae collection methods for xenomonitoring lymphatic filariasis in malaria co-infection context in Burkina Faso
• Assessment of mass drug administration for lymphatic filariasis elimination in the Armori and Chamorshi blocks of Gadchiroli District, Maharashtra: A cross-sectional study
• Atypical scrotal edema - Case report
• Beyond Tradition: Exploring Cutting-Edge Approaches for Accurate Diagnosis of Human Filariasis
• Bioactive components in Psidium guajava extracts elicit biotoxic attributes and distinct antioxidant enzyme modulation in the larvae of vectors of lymphatic filariasis and dengue
• Biosynthesis and characterization of <em>Ocimum sanctum</em> green silver nanoparticles and unravelling their enhanced anti-filarial activity through a HRAMS proteomics approach
• Biosynthesis and characterization of Ocimum sanctum green silver nanoparticles and unravelling their enhanced anti-filarial activity through a HRAMS proteomics approach
• Caught by Surprise - Microfilaria in Renal Biopsies
• Challenges and Solutions: Total Knee Replacement in Patients with Chronic Lymphatic Filariasis: A Case Report
• Combinations of the azaquinazoline anti-<em>Wolbachia</em> agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis
• Combinations of the azaquinazoline anti-Wolbachia agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis
• Comprehensive approach to in silico identification and in vitro validation of anti-filarial hit molecules targeting the dimer interface of thioredoxin peroxidase 1 in Wuchereria bancrofti: a progress in anti-filariasis drug development
• Deciphering the pH-dependent oligomerization of aspartate semialdehyde dehydrogenase from Wolbachia endosymbiont of Brugia malayi: An in vitro and in silico approaches
• Detection of Wuchereria bancrofti infection in mosquitoes in areas co-endemic with Brugia malayi in Balasore district, Odisha, India
• Distinguishing recrudescence from reinfection in lymphatic filariasis
• Dual RNA-seq in filarial nematodes and Wolbachia endosymbionts using RNase H based ribosomal RNA depletion
• Edge Artificial Intelligence (AI) for real-time automatic quantification of filariasis in mobile microscopy
• Effect of Adding a Six-Week Course of Doxycycline to Intensive Hygiene-Based Care for Improving Lymphedema in a Rural Setting of Mali: A Double-Blind, Randomized Controlled 24-Month Trial
• Efficacy and Feasibility of Short-Stretch Compression Therapy for Filarial Lymphedema in Sri Lanka
• Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study
• Elimination of lymphatic filariasis as a public health problem in Malawi
• Empowering lymphatic filariasis affected individuals in India: acknowledging disability status and ensuring justice
• Enhancing encapsulation of filarial antigen Brugia malayi thioredoxin in nano-liposomes: The role of lecithin composition
• Entomological assessment in 'hotspots' of four lymphatic filariasis endemic districts, Central Nepal during post-MDA surveillance
• Evaluation of Mass Drug Administration Coverage for Lymphatic Filariasis in the Lukonga Health Zone in 2022
• Evaluation of the International Task Force for Disease Eradication: A Review of Past Deliberations
• Factors associated with never treatment and acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana, 2021
• Factors influencing implementation of mass drug administration for lymphatic filariasis elimination: a mixed-method study in Odisha, India
• Field laboratory comparison of STANDARD Q Filariasis Antigen Test (QFAT) with Bioline Filariasis Test Strip (FTS) for the detection of Lymphatic Filariasis in Samoa, 2023
• Financial hardship among patients suffering from neglected tropical diseases: A systematic review and meta-analysis of global literature
• Ghana's path towards eliminating lymphatic filariasis
• Heterogeneity in elimination efforts could increase the risk of resurgence of lymphatic filariasis in Madagascar
• How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
• Identification and characterisation of Mansonella perstans in the Volta Region of Ghana
• Identification and characterization of a novel nematode pan allergen (NPA) from Wuchereria bancrofti and their potential role in human filarial tropical pulmonary eosinophilia (TPE)
• Immune targeting of filarial glutaredoxin through a multi-epitope peptide-based vaccine: A reverse vaccinology approach
• Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone
• Impact of conflict on the elimination targets of lymphatic filariasis, schistosomiasis and soil-transmitted helminths in Cabo Delgado province, Mozambique
• Impact of repeated mass ivermectin administration using a community directed approach on <em>L</em>. <em>loa</em> infection in <em>Chrysops silacea</em> of the rain forest and forest savanna of Cameroon
• Impediments to compliance during filariasis mass drug administration-Observations and recommendations to accelerate filariasis elimination in India
• Infectivity of Plasmodium parasites to Aedes aegypti and Anopheles stephensi mosquitoes maintained on blood-free meals of SkitoSnack
• Integrated Serosurveillance for Onchocerciasis, Lymphatic Filariasis, and Schistosomiasis in North Darfur, Sudan
• Integrating wing morphometrics and mitochondrial DNA analysis to assess the filaria vector Mansonia uniformis (Diptera: Culicidae) populations in Thailand
• LEDoxy-SL: A Placebo-Controlled, Double-Blind, Randomized, 24-Month Trial of Six Weeks of Daily Doxycycline Plus Hygiene-Based Essential Care for Reducing Progression of Filarial Lymphedema in Sri Lanka
• Leprosy and lymphatic filariasis-related disability and psychosocial burden in northern Mozambique
• Lessons from integrating mental health as part of lymphatic filariasis morbidity management and disability prevention services in Jigawa State, Nigeria
• Low schistosomiasis and soil-transmitted helminthiasis prevalence and intensities in selected communities in Davao de Oro and Davao del Norte, the Philippines: A setting for interruption of transmission?
• Lymphatic Filariasis
• Managing Lymphedema Induced by Lymphatic Filariasis: Implementing and Improving Care at the Individual and Programmatic Levels
• MBORS: Mosquito vector Biocontrol Ontology and Recommendation System
• Mitragyna parvifolia as apotential therapeutic agent for lymphatic filariasis
• Modelling the cost of engage & treat and test & treat strategies towards the elimination of lymphatic filariasis in Ghana
• Motivation-opportunity-ability-behaviour of community members and program implementers towards mass drug administration for lymphatic filariasis elimination in India: a systematic review and implementation priority
• Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration
• Operational research to inform post-validation surveillance of lymphatic filariasis in Tonga study protocol: History of lymphatic filariasis elimination, rational, objectives, and design
• Outcome Assessment of the implementation of Mass Drug Administration against Lymphatic Filariasis, in Kalaburagi (Gulbarga) District of Karnataka state: A Cross Sectional Survey
• Over 25 Years of Hope: Development of Lymphatic Filariasis Patient Support Groups in Haiti
• Oxidative stress induction by essential oil from Piper alatipetiolatum (Piperaceae) triggers lethality in the larvae of Culex quinquefasciatus (Diptera: Culicidae)
• Plasmacytoid urothelial carcinoma: a rare cause of localized lymphedema
• Podoconiosis in Uganda: prevalence, geographical distribution and risk factors
• Predictive Value of Microfilariae-Based Stop-MDA Thresholds After Triple Drug Therapy With IDA Against Lymphatic Filariasis in Treatment-Naive Indian Settings
• Preliminary study on buffy coat smear and molecular detection of microfilaria in domestic chickens (<em>Gallus gallus domesticus</em>) raised in Southern Thailand
• Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti
• Repurposed Drugs That Activate Autophagy in Filarial Worms Act as Effective Macrofilaricides
• Results of Integrated Transmission Assessment Surveys for Lymphatic Filariasis and Malaria in Haiti, 2017-2022
• Revisiting the antigen markers of vector-borne parasitic diseases identified by immunomics: identification and application to disease control
• Sero-antigen prevalence of lymphatic filariasis and risk factors of podoconiosis in Busiriba sub-county, Kamwenge district, Southwestern Uganda, August-September 2018
• Spatial distribution and environmental correlations of Culex pipiens pallens (Diptera: Culicidae) in Haidian district, Beijing
• Subnational Projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy
• Supermicrosurgical lymphovenous anastomosis
• Targeting a microbiota <em>Wolbachian</em> aminoacyl-tRNA synthetase to block its pathogenic host
• The effectiveness of albendazole against hookworm infections and the impact of bi-annual treatment on anaemia and body mass index of school children in the Kpandai district of northern Ghana
• The effects of selected neglected tropical diseases on economic performance at the macrolevel in Africa
• The impact of mosquito sampling strategies on molecular xenomonitoring prevalence for filariasis: a systematic review
• The impact of the National Programme to Eliminate Lymphatic Filariasis on filariasis morbidity in Sri Lanka: Comparison of current status with retrospective data following the elimination of lymphatic filariasis as a public health problem
• The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis
• The national distribution of lymphatic filariasis cases in Malawi using patient mapping and geostatistical modelling
• The psychosocial impacts of skin-neglected tropical diseases (SNTDs) as perceived by the affected persons: A systematic review
• Towards Understanding the Microepidemiology of Lymphatic Filariasis at the Community Level in Ghana
• Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment
• Unpacking Immune Modulation as a Site of Therapeutics Innovation for Nematode Parasite <em>Wuchereria bancrofti</em>: A Temporal Quantitative Phosphoproteomics Profiling of Macrophage Migration Inhibitory Factor 2
• Unraveling Lymphatic Filariasis in an Old Man: A Case Report
• Unveiling the intricacies of allosteric regulation in aspartate kinase from the Wolbachia endosymbiont of Brugia Malayi: Mechanistic and therapeutic insights
• What is the state of the art on traditional medicine interventions for zoonotic diseases in the Indian subcontinent? A scoping review of the peer-reviewed evidence base
• Wolbachia and Lymphatic Filarial Nematodes and Their Implications in the Pathogenesis of the Disease
• Wuchereria bancrofti Lymphatic Filariasis, Barrancabermeja, Colombia, 2023